Baker MP - Search Results

1

The INNs and outs of antibody nonproprietary names.

Jones TD, Carter PJ, Plückthun A, Vásquez M, Holgate RG, Hötzel I, Popplewell AG, Parren PW, Enzelberger M, Rademaker HJ, Clark MR, Lowe DC, Dahiyat BI, Smith V, Lambert JM, Wu H, Reilly M, Haurum JS, Dübel S, Huston JS, Schirrmann T, Janssen RA, Steegmaier M, Gross JA, Bradbury AR, Burton DR, Dimitrov DS, Chester KA, Glennie MJ, Davies J, Walker A, Martin S, McCafferty J, Baker MP. Jones TD, et al. Among authors: baker mp. MAbs. 2016;8(1):1-9. doi: 10.1080/19420862.2015.1114320. MAbs. 2016. PMID: 26716992 Free PMC article.

2

Circumventing immunogenicity in the development of therapeutic antibodies.

Holgate RG, Baker MP. Holgate RG, et al. Among authors: baker mp. IDrugs. 2009 Apr;12(4):233-7. IDrugs. 2009. PMID: 19350467 Review.

3

Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.

Holgate RG, Weldon R, Jones TD, Baker MP. Holgate RG, et al. Among authors: baker mp. PLoS One. 2015 Sep 15;10(9):e0138123. doi: 10.1371/journal.pone.0138123. eCollection 2015. PLoS One. 2015. PMID: 26372145 Free PMC article.

4

A comparison of the ability of the human IgG1 allotypes G1m3 and G1m1,17 to stimulate T-cell responses from allotype matched and mismatched donors.

Webster CI, Bryson CJ, Cloake EA, Jones TD, Austin MJ, Karle AC, Spindeldreher S, Lowe DC, Baker MP. Webster CI, et al. Among authors: baker mp. MAbs. 2016;8(2):253-63. doi: 10.1080/19420862.2015.1128605. Epub 2016 Jan 29. MAbs. 2016. PMID: 26821574 Free PMC article.

5

Deimmunization of monoclonal antibodies.

Jones TD, Crompton LJ, Carr FJ, Baker MP. Jones TD, et al. Among authors: baker mp. Methods Mol Biol. 2009;525:405-23, xiv. doi: 10.1007/978-1-59745-554-1_21. Methods Mol Biol. 2009. PMID: 19252848

6

Prediction of immunogenicity of therapeutic proteins: validity of computational tools.

Bryson CJ, Jones TD, Baker MP. Bryson CJ, et al. Among authors: baker mp. BioDrugs. 2010 Feb 1;24(1):1-8. doi: 10.2165/11318560-000000000-00000. BioDrugs. 2010. PMID: 20055528 Review.

7

A deimmunised form of the ribotoxin, α-sarcin, lacking CD4+ T cell epitopes and its use as an immunotoxin warhead.

Jones TD, Hearn AR, Holgate RGE, Kozub D, Fogg MH, Carr FJ, Baker MP, Lacadena J, Gehlsen KR. Jones TD, et al. Among authors: baker mp. Protein Eng Des Sel. 2016 Nov 1;29(11):531-540. doi: 10.1093/protein/gzw045. Protein Eng Des Sel. 2016. PMID: 27578884 Free PMC article.

8

Ascorbic acid ameliorates renal injury in a murine model of contrast-induced nephropathy.

Rollins K, Noorani A, Janeckova L, Jones T, Griffiths M, Baker MP, Boyle JR. Rollins K, et al. Among authors: baker mp. BMC Nephrol. 2017 Mar 24;18(1):101. doi: 10.1186/s12882-017-0498-5. BMC Nephrol. 2017. PMID: 28340561 Free PMC article.

9

Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.

Jones TD, Phillips WJ, Smith BJ, Bamford CA, Nayee PD, Baglin TP, Gaston JS, Baker MP. Jones TD, et al. Among authors: baker mp. J Thromb Haemost. 2005 May;3(5):991-1000. doi: 10.1111/j.1538-7836.2005.01309.x. J Thromb Haemost. 2005. PMID: 15869596 Free article.

10

The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection.

Jones TD, Hanlon M, Smith BJ, Heise CT, Nayee PD, Sanders DA, Hamilton A, Sweet C, Unitt E, Alexander G, Lo KM, Gillies SD, Carr FJ, Baker MP. Jones TD, et al. Among authors: baker mp. J Interferon Cytokine Res. 2004 Sep;24(9):560-72. doi: 10.1089/jir.2004.24.560. J Interferon Cytokine Res. 2004. PMID: 15450132

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page